Reviva Pharmaceuticals Holdings, Inc. (RVPH) shareholders
Close on Oct 19, 2026Market cap $5.94MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Highbridge Capital Management, LLC | 8,000,000 | 9.90% | 13G (passive) | Jun 30, 2025 |
| 683 Capital Partners, LP Joint filing with 683 Capital Management, LLC (5.36%), Zweiman Ari (5.36%) | 5,435,000 | 5.36% | 13G (passive) | Sep 22, 2025 |
| Heights Capital Management, Inc. Joint filing with CVI Investments, Inc. (5.90%) | 4,000,000 | 5.90% | 13G (passive) | Jun 26, 2025 |
| Tang Capital Management, LLC Joint filing with Kevin Tang (7.80%), Tang Capital Partners, LP (7.29%) | 3,910,304 | 7.80% | 13G (passive) amendment | Mar 31, 2025 |
| Steven Boyd Joint filing with Armistice Capital, LLC (9.99%) | 3,357,953 | 9.99% | 13G (passive) amendment | Sep 30, 2024 |
| Tang Capital Partners, LP Joint filing with Tang Capital Management, LLC (9.99%), Kevin Tang (9.99%) | 3,098,615 | 9.99% | 13G (passive) amendment | Dec 31, 2023 |
| Millennium Group Management LLC Joint filing with Integrated Core Strategies (US) LLC (8.20%), Millennium Management LLC (8.20%) and 1 more | 1,072,690 | 8.20% | 13G (passive) amendment | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of RVPH | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| EMC Capital Management | 6,696 | 0.05% | $3.00K | New | 0.00% |
| TD Waterhouse Canada Inc. | 625 | 0.00% | $412 | – | 0.00% |
| Purpose Unlimited Inc. | 405 | 0.00% | $259 | – | 0.00% |
| Mosley Wealth Management | 1 | 0.00% | $1 | New | 0.00% |
| Miller Global Investments, LLC | 1 | 0.00% | $1 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 5 | 0M | 0.1% | 3 / 0 | 0 / 33 | 0M | 3M |
| Q1 2026 | 35 | 3M | 22.3% | 14 / 7 | 4 / 22 | 3M | 0M |
| Q4 2025 | 46 | 1M | 4.3% | 14 / 12 | 9 / 9 | 0M | 0M |
| Q3 2025 | 41 | 0M | 3.6% | 7 / 10 | 10 / 11 | 0M | 0M |
| Q2 2025 | 46 | 1M | 5.5% | 11 / 9 | 9 / 13 | 0M | 0M |
| Q1 2025 | 49 | 0M | 2.8% | 19 / 11 | 9 / 12 | 0M | 0M |
| Q4 2024 | 42 | 0M | 3.0% | 18 / 10 | 8 / 9 | 0M | 0M |
| Q3 2024 | 33 | 0M | 3.8% | 9 / 8 | 7 / 5 | 0M | 0M |
| Q2 2024 | 31 | 0M | 2.6% | 9 / 12 | 4 / 5 | 0M | 0M |
| Q1 2024 | 28 | 0M | 2.1% | 3 / 12 | 5 / 11 | 0M | 0M |
| Q4 2023 | 36 | 0M | 2.0% | 16 / 14 | 3 / 3 | 0M | 0M |
| Q3 2023 | 24 | 0M | 1.0% | 5 / 8 | 8 / 4 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
8 funds held RVPH in Q1 2026, 72% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of RVPH | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Nasdaq Composite Index Fund | 998 | 0.01% | $408 | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Laxminarayan Bhat | President and CEO, Director | 2,484,244 | 18.95% | Mar 20, 2026 |
| Narayan Prabhu | Chief Financial Officer | 100,000 | 0.76% | Mar 20, 2026 |
| Parag Saxena | Director | 4,046,000 | 30.86% | Dec 19, 2025 |
| Leslie D. Funtleyder | Director | – | – | Dec 19, 2025 |
| Purav Patel | Director | 75,607 | 0.58% | Dec 19, 2025 |
| Richard A. Margolin | Director | – | – | Dec 19, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Purav Patel Director | Nov 18, 2022 | Buy | +3,000 | $4.69 | $14.07K | 43,547 |
| Narayan Prabhu Chief Financial Officer | Sep 30, 2022 | Buy | +50,000 | $1.66 | $83.00K | 100,000 |
| Narayan Prabhu Chief Financial Officer | Jun 30, 2022 | Buy | +50,000 | $1.21 | $60.50K | 50,000 |
| Vedanta Associates-R, LP 10% owner | Jun 1, 2021 | Buy | +399,000 | $3.75 | $1.50M | 399,000 |
| Vedanta Associates-R, LP 10% owner | Jun 1, 2021 | Buy | +931,000 | $3.75 | $3.49M | 931,000 |
| Parag Saxena Director, 10% owner | Dec 14, 2020 | Award | +197,500 | – | – | 2,121,750 |
| Glazer Capital, Llc 10% owner | Dec 8, 2020 | Sale | −367,000 | $10.88 | $3.99M | 0 |
| Sander Gerber 10% owner | Dec 8, 2020 | Other | −710,000 | $10.88 | $7.72M | 0 |
| Sander Gerber 10% owner | Dec 7, 2020 | Sale | −50,000 | $11.51 | $575.50K | 710,000 |
| Glazer Capital, Llc 10% owner | Dec 3, 2020 | Other | −606,360 | $10.88 | $6.60M | 0 |
| Paul J. Glazer 10% owner | Dec 2, 2020 | Sale | −261 | $11.00 | $2.87K | 606,360 |
| Glazer Capital, Llc 10% owner | Dec 1, 2020 | Sale | −5,362 | $11.00 | $58.98K | 606,621 |
| Glazer Capital, Llc 10% owner | Nov 27, 2020 | Sale | −5,969 | $10.90 | $65.06K | 611,983 |
| Paul J. Glazer 10% owner | Nov 24, 2020 | Sale | −7,103 | $10.90 | $77.42K | 617,952 |
| Paul J. Glazer 10% owner | Nov 23, 2020 | Sale | −23,611 | $10.90 | $257.36K | 625,055 |
| Paul J. Glazer 10% owner | Nov 18, 2020 | Sale | −896 | $10.90 | $9.77K | 648,666 |
| Paul J. Glazer 10% owner | Nov 17, 2020 | Sale | −127 | $10.90 | $1.38K | 649,562 |
| Paul J. Glazer 10% owner | Nov 16, 2020 | Sale | −305 | $10.90 | $3.32K | 649,689 |
| Glazer Capital, Llc 10% owner | Nov 11, 2020 | Sale | −5 | $10.90 | $55 | 649,994 |
| Paul J. Glazer 10% owner | Nov 6, 2020 | Sale | −1 | $10.90 | $11 | 649,999 |
| Paul J. Glazer 10% owner | Nov 3, 2020 | Sale | −57,616 | $10.85 | $625.13K | 650,000 |
| Paul J. Glazer 10% owner | Nov 2, 2020 | Sale | −1 | $11.50 | $12 | 707,616 |
| Sander Gerber 10% owner | Nov 2, 2020 | Sale | −50,000 | $10.87 | $543.50K | 760,000 |
| Paul J. Glazer 10% owner | Sep 29, 2020 | Sale | −2 | $11.50 | $23 | 707,617 |
| Paul J. Glazer 10% owner | Sep 17, 2020 | Sale | −1,000 | $10.80 | $10.80K | 707,619 |
| Paul J. Glazer 10% owner | Sep 14, 2020 | Sale | −1 | $10.80 | $11 | 708,619 |
| Securities Usa Llc Mizuho 10% owner | May 8, 2020 | Sale | −51,000 | $10.62 | $541.62K | 766,750 |
| Sander Gerber 10% owner | Mar 20, 2020 | Buy | +10,000 | $10.37 | $103.70K | 810,000 |
| LLC Tenzing 10% owner | Aug 30, 2018 | Buy | +33,000 | $10.00 | $330.00K | 1,924,250 |
| Rahul Nayar Chief Executive Officer, Director, 10% owner | Aug 30, 2018 | Buy | +33,000 | $10.00 | $330.00K | 1,924,250 |
| Parag Saxena Chairman of the Board, Director, 10% owner | Aug 30, 2018 | Buy | +33,000 | $10.00 | $330.00K | 1,924,250 |
| Rahul Nayar Chief Executive Officer, Director, 10% owner | Aug 23, 2018 | Buy | +310,000 | $10.00 | $3.10M | 1,891,250 |
| Parag Saxena Chairman of the Board, Director, 10% owner | Aug 23, 2018 | Buy | +310,000 | $10.00 | $3.10M | 1,891,250 |
| LLC Tenzing 10% owner | Aug 23, 2018 | Buy | +310,000 | $10.00 | $3.10M | 1,891,250 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Reviva Pharmaceuticals's stock actually held short. Settlement fails (shares not delivered on time) peaked at 368 shares on Sep 2, 2026 over the last 90 days.
See a number that looks wrong?